← Leaderboards
Jeffrey Andrew Sparks
Brigham And Women'S Hospital
$7,186,255
Attributed
$8,312,308
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,728,569 · 6
By mechanism
R01$7,367,234 · 3
P30$4,416,261 · 1
K23$766,074 · 1
R03$179,000 · 1
Top collaborators
- Peter A Nigrovic5 shared
- Elizabeth W Karlson2 shared
- George R Washko2 shared
- Zachary Scott Wallace1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Daniel Hal Solomon$26,002,677
- Raul San Jose Estepar$11,331,173
- Farbod Nicholas Rahaghi$4,904,428
- Elizabeth W Karlson$93,612,751
- James A. Lederer$21,491,638
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeWomanHospitalsMedicineProspectiveCohortRheumatoid ArthritisAffectLinkMedical SchoolsAutoimmunityProfessorAutoantibodiesAwardImageLungRisk FactorsMortalityMorbidity - Disease RateProspective CohortAdultInterstitial Lung DiseasesSmokingSampling
Grant awards (23)
Joint Biology Consortium Resource-based Center$803,723
P30 · FY2025 · AR
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes$736,799
R01 · FY2025 · HL
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases$706,210
R01 · FY2025 · AR · contact PI
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease$694,961
R01 · FY2025 · AR · contact PI
Joint Biology Consortium Resource-based Center$893,027
P30 · FY2024 · AR
Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes$732,797
R01 · FY2024 · HL
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease$720,738
R01 · FY2024 · AR · contact PI
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases$716,336
R01 · FY2024 · AR · contact PI
Joint Biology Consortium Resource-based Center$893,027
P30 · FY2023 · AR
Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases$782,510
R01 · FY2023 · AR · contact PI
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease$738,566
R01 · FY2023 · AR · contact PI
Joint Biology Consortium Resource-based Center$893,213
P30 · FY2022 · AR
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease$723,953
R01 · FY2022 · AR · contact PI
Joint Biology Consortium Resource-based Center$933,271
P30 · FY2021 · AR
Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease$814,364
R01 · FY2021 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$142,627
K23 · FY2020 · AR · contact PI
Respiratory Diseases, Genetics, and Rheumatoid Arthritis Risk$89,500
R03 · FY2020 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$148,837
K23 · FY2019 · AR · contact PI
Respiratory Diseases, Genetics, and Rheumatoid Arthritis Risk$89,500
R03 · FY2019 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$886
K23 · FY2019 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$158,153
K23 · FY2018 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$157,908
K23 · FY2017 · AR · contact PI
Rheumatoid Arthritis and Respiratory Outcomes in Prospective Cohorts$157,663
K23 · FY2016 · AR · contact PI